Speaker :

Dr. Bhuvan Chugh, Medical Oncologist, Delhi

Abemaciclib Combined With Endocrine Therapy for the Adjuvant Treatment of HR+, HER2-, Node-Positive, High-Risk, Early Breast Cancer (monarchE)

Author: Stephen R D Johnston

Citation: J Clin Oncol. 2020 Dec 1;38(34):3987-3998

Primary outcome analysis of invasive disease-free survival for monarchE: abemaciclib  combined with adjuvant endocrine therapy for high risk early breast cancer

Author: O’Shaughnessy JA

Citation: SABCS Abstract GS1-01